Faculty Spotlight: John T. Wilson, Ph.D.
Anna E. Patrick, MD, PhD
Dr. Patrick's work focuses on identifying and characterizing pathogenic molecular pathways in juvenile idiopathic arthritis and pediatric autoimmune disease. Her research program employs the study of rare monogenetic mutations associated with disease manifestations to discover novel pathways involved in autoimmunity. This strategy defines the relationship of these pathways to the broader disease population. She has elucidated the role of GATA3, a gene critical for T cell differentiation and function, in juvenile idiopathic arthritis. Her research program involves studies in primary human cells using molecular biology, immunology, and next generation sequencing techniques.
Publications on 
Juvenile Idiopathic Arthritis, Autoimmune Disease, Autoinflammatory Disease, Immunology, Genetics
Recommended Reading - October 4th, 2020
Spotlight: Schmitz Lab
Faculty Spotlight: Brent Ferrell, M.D.
Recommended Reading - September 6th, 2020
Postdoc Spotlight: Todd Bartkowiak, PhD
Graduate Student Spotlight: Benem-Orom Davids
Cinque Soto, Ph.D.
Dr. Soto received his PhD in molecular biophysics from Columbia University's School of Medicine. After receiving his PhD, Cinque went on to carry out postdoctoral studies at the University of Pennsylvania's School of Medicine where he developed computational methods for in silico modeling and design of helical transmembrane proteins. Following his postdoctoral studies, Cinque took a senior scientist position at SCHRODINGER, a computational software company, where he worked on the development of small-molecule docking methods for in silico drug design. In 2013, Cinque left the software industry to become co-head of the structural bioinformatics core section (SBIS) at NIAID’s Vaccine Research Center (VRC). At the VRC, Cinque focused on analyzing antibody repertoires from next-generation sequencing (NGS). Cinque continues working on the development of bioinformatics methods for analyzing antibody and T cell receptor repertories at the Vanderbilt Vaccine Center.